Business News • MarketWire • Ritter Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock |
Ritter Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock |
|
|
Ritter Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
LOS ANGELES, CA--(Marketwired - Oct 25, 2016) - Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases with its lead product, RP-G28, being developed for the treatment of lactose intolerance, today announced that it intends to offer for sale shares of its common stock in an underwritten public offering. The company intends to use the net proceeds from this offering for working capital and to fund other general corporate purposes. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
View More : http://www.marketwired.com/mw/release.do?id=2169689&sourceType=3
|
|
|